entertainment -WSS

entertainment

author：comprehensive 2025-08-25 16:34:05 - browse：4162

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Sen. Bill Cassidy on how to lower drug prices

WSS

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Eli Lilly CEO gives to Mike Pence presidential super PAC

With fresh data, a dynamic duo powers Eli Lilly to new heights

White House Covid adviser calls on docs to combat misinformation

White House Covid adviser calls on docs to combat misinformation

Assistant physicians can help address the primary care shortage

leisure time

entertainment

entertainment

Activists slam private health insurers over coverage restrictions

Covid’s new normal has set in amid another rise in cases

As demand for Covid shots wanes, Moderna seeks its next success

How corporate America is slashing DEI workers amid backlash to diversity programs

At least 13 dead in Texas as scorching temps continue

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Activists slam private health insurers over coverage restrictions

House panel to mark up pandemic

Walensky prepares to leave CDC — and Congress — behind

How redistricting in 6 states could affect who controls Congress

focus

US intelligence assessment says Iran not currently developing nuclear weapons

FDA panel to weigh safety of artificial wombs for preterm births

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Neutralizing antibodies against HIV shows promise in children

What happened to the House vote on health price transparency?

FDA weighs limits of animal data in assessing artificial wombs

focus

focus

explore

hotspot